KM

Kobie Mouton

Chief Executive Officer at XLTA Cure

No bio yet


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


XLTA Cure

XLTA® represents the next generation in advanced wound care, offering a range of superabsorbent hydrocapillary dressings designed to accelerate healing for acute and chronic wounds. Utilizing a proprietary triple-action mechanism—hydrocapillary flow, electrostatic charge, and proteolytic enzyme balance—XLTA® effectively manages exudate, reduces bioburden, and promotes autolytic debridement without the use of chemicals or medications. With dual non-adherent layers, XLTA® ensures atraumatic removal and improved patient comfort. Every aspect of XLTA® is engineered to simplify wound management, enhance clinical outcomes, and redefine standards in wound care.


Employees

11-50

Links